NeuroSense Therapeutics Ltd. (NRSNW)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$11.09M | -$9.90M | -$12.05M | -$10.55M | -$2.98M | — |
| Net Income | -$11.12M | -$10.21M | -$10.11M | -$10.49M | -$3.22M | — |
| EPS (Diluted) | $-0.44 | $-0.54 | $-0.74 | $-0.91 | $-0.52 | — |
| Total Assets | $1.03M | $4.58M | $3.19M | $7.72M | — | — |
| Total Liabilities | $2.59M | $1.99M | $4.94M | $1.87M | — | — |
| Shareholders' Equity | -$1.56M | $2.58M | -$1.76M | $5.84M | $10.83M | $659.0K |
| Cash & Equivalents | $166.0K | $3.38M | $2.64M | $3.54M | — | — |
| Operating Cash Flow | -$7.67M | -$10.13M | -$8.35M | -$7.62M | -$1.54M | — |
| Capital Expenditures | $8.0K | $3.0K | $29.0K | $70.0K | $17.0K | — |
| Shares Outstanding | 32.56M | 23.23M | 15.38M | 11.78M | — | — |